Ad is loading...
DTSGX
Price
$18.20
Change
+$0.32 (+1.79%)
Updated
Nov 22 closing price
VISGX
Price
$83.69
Change
+$1.46 (+1.78%)
Updated
Nov 22 closing price
Ad is loading...

DTSGX vs VISGX

Header iconDTSGX vs VISGX Comparison
Open Charts DTSGX vs VISGXBanner chart's image
Wilshire Small Company Growth Invmt
Price$18.20
Change+$0.32 (+1.79%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Growth Index I
Price$83.69
Change+$1.46 (+1.78%)
VolumeN/A
CapitalizationN/A
DTSGX vs VISGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DTSGX vs. VISGX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTSGX is a StrongBuy and VISGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VISGX has more cash in the bank: 35.8B vs. DTSGX (26.2M). VISGX pays higher dividends than DTSGX: VISGX (0.55) vs DTSGX (0.00). DTSGX was incepted earlier than VISGX: DTSGX (32 years) vs VISGX (27 years). DTSGX is a more actively managed with annual turnover of: 81.00 vs. VISGX (19.00). VISGX has a lower initial minimum investment than DTSGX: VISGX (3000) vs DTSGX (250000). VISGX annual gain was more profitable for investors over the last year : 38.08 vs. DTSGX (24.32). VISGX return over 5 years is better than : 56.17 vs. DTSGX (-31.68).
DTSGXVISGXDTSGX / VISGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years27 years-
Gain YTD11.93123.35851%
Front LoadN/AN/A-
Min. Initial Investment25000030008,333%
Min. Initial Investment IRAN/AN/A-
Net Assets26.2M35.8B0%
Annual Yield % from dividends0.000.55-
Returns for 1 year24.3238.0864%
Returns for 3 years-49.364.27-1,157%
Returns for 5 years-31.6856.17-56%
Returns for 10 years-28.43140.98-20%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGL1.890.11
+6.18%
agilon health
ONON58.131.94
+3.45%
On Holding AG
ALT8.680.28
+3.27%
Altimmune
CGEN1.41-0.04
-2.76%
Compugen Ltd
EVOK4.33-0.17
-3.78%
Evoke Pharma, Inc.